TRML logo

Tourmaline Bio, Inc. (TRML) Shareholders equity

annual shareholders equity:

$300.05M+$95.01M(+46.34%)
December 31, 2024

Summary

  • As of today (September 15, 2025), TRML annual stockholders equity is $300.05 million, with the most recent change of +$95.01 million (+46.34%) on December 31, 2024.
  • During the last 3 years, TRML annual shareholders equity has risen by +$57.24 million (+23.58%).
  • TRML annual shareholders equity is now at all-time high.

Performance

TRML Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLbalance sheet metrics

quarterly shareholders equity:

$259.19M-$20.67M(-7.39%)
June 30, 2025

Summary

  • As of today (September 15, 2025), TRML quarterly stockholders equity is $259.19 million, with the most recent change of -$20.67 million (-7.39%) on June 30, 2025.
  • Over the past year, TRML quarterly shareholders equity has dropped by -$79.09 million (-23.38%).
  • TRML quarterly shareholders equity is now -26.81% below its all-time high of $354.14 million, reached on March 31, 2024.

Performance

TRML quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TRML Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+46.3%-23.4%
3 y3 years+23.6%+23.0%
5 y5 years+657.9%-

TRML Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+3958.6%-26.8%+3405.9%
5 y5-yearat high+3958.6%-26.8%+3405.9%
alltimeall timeat high+3958.6%-26.8%+3405.9%

TRML Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$259.19M(-7.4%)
Mar 2025
-
$279.86M(-6.7%)
Dec 2024
$300.05M(+46.3%)
$300.05M(-6.5%)
Sep 2024
-
$321.07M(-5.1%)
Jun 2024
-
$338.28M(-4.5%)
Mar 2024
-
$354.14M(+72.7%)
Dec 2023
$205.04M(+2673.5%)
$205.04M(+43.5%)
Sep 2023
-
$142.87M(-3.7%)
Jun 2023
-
$148.43M(-8.2%)
Mar 2023
-
$161.73M
DateAnnualQuarterly
Dec 2022
$7.39M(-97.0%)
-
Dec 2022
-
$7.39M(-96.2%)
Sep 2022
-
$194.87M(-7.5%)
Jun 2022
-
$210.74M(-6.8%)
Mar 2022
-
$226.03M(-6.9%)
Dec 2021
$242.81M(+64.1%)
$242.81M(-5.0%)
Sep 2021
-
$255.65M(-4.4%)
Jun 2021
-
$267.35M(+91.4%)
Mar 2021
-
$139.69M(-5.6%)
Dec 2020
$148.00M(+273.9%)
$148.00M
Dec 2019
$39.59M
-

FAQ

  • What is Tourmaline Bio, Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. annual shareholders equity year-on-year change?
  • What is Tourmaline Bio, Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. quarterly shareholders equity year-on-year change?

What is Tourmaline Bio, Inc. annual stockholders equity?

The current annual shareholders equity of TRML is $300.05M

What is the all time high annual shareholders equity for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high annual stockholders equity is $300.05M

What is Tourmaline Bio, Inc. annual shareholders equity year-on-year change?

Over the past year, TRML annual stockholders equity has changed by +$95.01M (+46.34%)

What is Tourmaline Bio, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of TRML is $259.19M

What is the all time high quarterly shareholders equity for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high quarterly stockholders equity is $354.14M

What is Tourmaline Bio, Inc. quarterly shareholders equity year-on-year change?

Over the past year, TRML quarterly stockholders equity has changed by -$79.09M (-23.38%)
On this page